It’s amazing the number of CBD products that are now available to purchase in the United States.
I first started to see them in 2014 after the passage of the initial Farm Bill, but the retailers at the time were operating within a legal grey area.
No a single was completely sure whether or not the Farm Bill contradicted language within the Controlled Substance Act, and the fear alone was enough to prevent more companies from jumping on board with producing industrial hemp products. When the 2018 Farm Bill reaffirmed the legal status of industrial hemp, the market exploded overnight. Suddenly major national retailers were carrying CBD and full spectrum hemp products in their pharmacies and at their checkout counters, and but CBD is just a single among hundreds of other cannabinoids found in the marijuana plant, plus plants that fall within the umbrella of federally compliant hemp. One current form of CBD is called CBD-HQ or just CBDQ. It has a quinone linked to its molecule, which are the compounds responsible for the natural browning process in plums as they age. When CBDQ is extracted and exposed to oxygen, it retains a brownish purple color. Like traditional CBD, CBDQ is being studied to target and reduce cancer cells. More research needs to be done to back up existing data, but there is consistent confirmation for its efficacy in pain relief. This is important because cannabinoids love CBD and CBDQ are safe alternatives for chronic pain patients who want to avoid opiates with their multiple negative side effects. Many of these cannabinoids can be bought as bulk isolates on the internet, giving patients the ability to self-medicate with these compounds naturally found in the cannabis plant.